50 Doctors Hospital, Puebla, Mexico

Dr. Celma replies by email · Send an enquiry

Patient story

Hope arrives: a daughter's story

Paula, 57, was living with lung and bone cancer. Her daughter Sara describes how the family found GcMAF.

Infographic: Cancer wonder drug with zero toxicity? A daughter's story of hope. Paula, age 57, lung and bone cancer, before and after GcMAF.
The infographic shared by Dr. Celma. The images are illustrations.

Paula, age 57: lung and bone cancer

Paula had been fighting cancer for three years. She had three rounds of chemotherapy, and radiation reduced the cancer in her bones, but the lung cancer continued. In February 2025 the family were told there was no curative approach.

Before

  • Advanced lung cancer
  • A permanent drain in her lungs
  • Oxygen support 24 hours a day
  • Unable to get out of bed
  • Weak, in pain and gasping for air

September 2026

  • Lung cancer can no longer be detected
  • Breathing without oxygen
  • Fully mobile
  • Only one tiny cancerous spot remains in the lumbar spine
  • A new lease of life
We were told there was no curative approach. My mother was gasping for air. We felt hopeless.Sara, Paula's daughter

How we found GcMAF

  1. A colleague mentioned it

    A work colleague mentioned GcMAF, which was not known for side effects.

  2. Reading about it

    The family found GcMAF.com and the book Immune Health, Terrain and GcMAF.

  3. Starting treatment

    They ordered GcMAF and Paula started nebulising it.

  4. The first four weeks

    Within four weeks there was less fluid in her lungs, and she could breathe for periods without oxygen.

  5. Meeting Maryjayne

    They met Maryjayne Aria in Istanbul during a layover. She reviewed all of Paula's medical records and suggested a cautious protocol.

My mother now has hope of a continued life. She calls GcMAF her G Wonder Drug. It offers hope without toxicity.Sara, Paula's daughter

Dr. Celma also uses GcMAF together with mesenchymal stem cells in some of his patients. Read about his experience in Parkinson's disease: combining MSCs and GcMAF.

Ask Dr. Celma about treatment

Send a short description of the condition and Dr. Celma will reply to you personally by email.